Global Atrial Fibrillation Devices Market 2019-2025
|出版商||Orion Market Research Pvt Ltd||商品編碼||888707|
|心房纖維顫動設備的全球市場:2019年∼2025年 Global Atrial Fibrillation Devices Market 2019-2025|
|出版日期: 2019年07月02日||內容資訊: 英文||
Global Atrial Fibrillation Devices Market Size, Share & Trends Analysis Report by Product (Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology, Mapping and Recording Systems, Cardiac Monitors, and Others), by End-User (Hospitals & Clinics and Ambulatory Surgical Centers), and Forecast, 2019 - 2025
Atrial fibrillation is an irregular heartbeat that leads to an increased risk of stroke and other heart-related diseases. It is one of the most common types of arrhythmias that resulting heart to beat much faster than normal. During atrial fibrillation, the blood pools in the heart that increase the risk of developing a stroke or other heart-related complications. The global atrial fibrillation devices market is expected to exhibit considerable growth during the forecast period. The market growth is attributed to increasing cases of atrial fibrillation coupled with the rising geriatric population, which surges the demand for atrial fibrillation devices for the treatment of disease. In addition, increasing demand for catheter ablation procedures is boosting the growth of the market.
The global atrial fibrillation devices market is segmented on the basis of product (electrophysiology ablation catheters, electrophysiology diagnostic catheters, electrophysiology, mapping and recording systems, cardiac monitors, and others) and end-user (hospitals and clinics and ambulatory surgical centers). Among the products, electrophysiology ablation catheters are expected to contribute significantly to the market growth. In addition, the application of atrial fibrillation devices is the highest in hospitals and clinics owing to an increasing proportion of cardiac surgeries performed coupled with the availability of skilled cardiac surgeons in the hospitals.
Geographically, the market report includes the study of four major regions; North America (US, Canada), Europe (Germany, UK, Spain, Italy, France, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and Rest of the World (RoW). Asia-Pacific is expected to witness optimistic growth during the forecast period. Increasing cases of cardiac diseases coupled with the rising geriatric population are one of the major factors spurring the growth of the market in the Asia-Pacific region. Moreover, North America is expected to hold a prominent position in the global market due to the major contribution from the US coupled with the presence of key market players, such as Johnson & Johnson, Abbott Laboratories Inc., and Boston Scientific Corp. in the region.
Further, the global atrial fibrillation market is dominated by some of the leading players that include Abbott Laboratories Inc., Johnson & Johnson, Boston Scientific Corp., Siemens AG, Medtronic PLC, Atricure Inc., Microport Scientific Corp., and Koninklijke Philips N.V. These players with a robust product line and strong financial condition contribute major share in the revenue generation of the global atrial fibrillation market.
The market study of the global atrial fibrillation devices market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
The report is intended for healthcare organizations, medical device manufacturers, original equipment manufacturers (OEM), market research firms, investment companies, government societies for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.